JW Pharma ApS: Financial statements 2018
CVR: 39330563
Source: annual report 2018, Danish Business Authority
12/02/2018 – 31/12/2018
JW Pharma ApS (CVR 39330563) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -85,066 and a net result of DKK -86,752. Equity in the 2018 report amounted to DKK -36,752.
- Gross Profit
- DKK -85,066
- Profit/Loss
- DKK -86,752
- Equity
- DKK -36,752
- Total Assets
- DKK 582,853
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of April 12, 2018, Jie Chen has joined the board of directors of JW Pharma ApS.
As of April 12, 2018, Yan Wong is registered as chairman of JW Pharma ApS.
As of February 12, 2018, Jun Chen is registered as director of JW Pharma ApS.
JW Pharma ApS was founded on February 12, 2018.
About JW Pharma ApS
JW Pharma ApS was a Danish company of the type Anpartsselskab based in København S, founded in 2018. The company has been dissolved on 27 October 2025. The company was registered under the industry Detailhandel med andre fødevarer. In 2024, the company reported a gross profit of DKK -5,857 and a net result of DKK -5,857 compared with DKK -4,637 the year before. Equity in the 2024 report amounted to DKK -147,099.